BK Irons, RS Greene, TA Mazzolini, KL … - Pharmacotherapy, 2006 - PPI Brian K. Irons, Pharm.D., Ronald Shane Greene, Pharm.D., Timothy A. Mazzolini,
Pharm.D., Krystal L. Edwards, Pharm.D., and Rebecca B. Sleeper, Pharm.D. ...
Clinical data suggest that thiazolidinediones—specifically, rosiglitazone ... Cited by 27 - Related articles - BL Direct - All 3 versions
SV Edelman, RR Henry, 2009 - books.google.com Copyright 2009 Steven V. Edelman, MD, Robert R. Henry, MD Professional
Communications, Inc. A Medical Publishing Company Marketing Office: Editorial
Office: 400 Center Bay Drive PO Box 10 West Islip, NY 11795 Caddo, OK ... Cited by 19 - Related articles - BL Direct - All 4 versions
M Dobretsov, D Romanovsky, JR Stimers - World journal of gastroenterology: WJG, 2007 - pubmedcentral.nih.gov Peripheral neuropathy, and specifically distal peripheral neuropathy (DPN), is
one of the most frequent and troublesome complications of diabetes mellitus. It
is the major reason for morbidity and mortality among diabetic patients. It ... Cited by 19 - Related articles - BL Direct - All 7 versions
H Bihan, S Laurent, C Sass, G Nguyen, C … - Diabetes Care, 2005 - Am Diabetes Assoc OBJECTIVE—Previous studies have related poor glycemic control and/or some
diabetes complications to low socioeconomic status. Some aspects of
socioeconomic status have not been assessed in these studies. In the ... Cited by 15 - Related articles - BL Direct - All 5 versions
IW Campbell, S Mariz - Diabetes research and clinical practice, 2007 - Elsevier Progressive β-cell dysfunction and β-cell failure are fundamental pathogenic
features of type 2 diabetes. Ultimately, the development and continued
progression of diabetes is a consequence of the failure of the β-cell to ... Cited by 13 - Related articles - All 11 versions
BJ Goldstein - International journal of clinical practice, 2006 - interscience.wiley.com Recent clinical research has provided a wealth of information to support optimal
management strategies in type 2 diabetes mellitus (T2DM). In particular, outcome
studies appropriately have had an increasingly important impact on clinical ... Cited by 13 - Related articles - BL Direct - All 5 versions
E Karathanasis, R Bhavane, AV Annapragada - Journal of Controlled Release, 2006 - Elsevier An aerosol insulin carrier based on the agglomerated vesicle technology that the
authors have previously advanced [E. Karathanasis et al. J. Control. Release 103
(2005) 159–175] was evaluated in vivo. The carrier consisted of ... Cited by 7 - Related articles - All 3 versions
VA Fonseca - J Clin Hyperten, 2006 - interscience.wiley.com Insulin resistance, diabetes mellitus, and hypertension are associated with
significant cardiovascula: morbidity and mortality. Lifestyle modifications
effectively decrease the risk of progression to diabetes in high-risk ... Cited by 6 - Related articles - BL Direct - All 5 versions
CY Pan - Current diabetes reviews, 2007 - ingentaconnect.com Abstract: The severity of the type 2 diabetes epidemic is widely acknowledged.
Demographic, social, and cultural changes around the world are driving a
dramatic increase in the prevalence of type 2 diabetes. Consequently, there ... Cited by 3 - Related articles - BL Direct - All 3 versions
